Opdivo (nivolumab) is an FDA- approved immunotherapy cancer drug treatment that is showing great promise for treating various types of cancer, including melanoma, lung cancer, kidney cancer and Hodgkin lymphoma. As a disease, cancer escapes the immune system by producing certain proteins that can hide it. As the cancer can cloak itself, the immune system does not detect it. Opdivo is an antibody that binds to the protein called PD-1 on T cells that live in our immune system. T-cells are like a car ignition that gets the immune system off and running, helping it find and kill cancer cells. In this video, oncologist Dr. Stephen Lemon provides an overview about this cancer treatment.
#Opdivo (nivolumab) is developed by Bristol-Myers Squibb. Besides being FDA approved for the treatment of certain cancers like #melanoma and lung cancer, Opdivo is also being studied for the treatment of many other types of cancer.
These videos are produced by Dr. Stephen Lemon to help provide useful cancer information to patients and survivors. Dr. Lemon practices with the Overlake Cancer Center in the Seattle, WA area. (Oncology Associates)